reference/20950726

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/20950726

Outgoing Links

Predicate	Object
contentType	Journal Article\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	2709
issn	1535-7163 1538-8514
issueIdentifier	12
pageRange	2702-2709
publicationName	Molecular Cancer Therapeutics
startingPage	2702
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_c81c82b4ad9caa060230b3c9689699b7 http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_55dd225a703b2797a532d009e7ea788e http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_0651917fa8dfd6057840363ce2a20f9c http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_25a8acaa68fa352f29ed22920a85312d
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_223b6e12fee4a2cb82a5b015891b0b7e
bibliographicCitation	Chamberlain CE, German MS, Yang K, Wang J, VanBrocklin H, Regan M, Shokat KM, Ducker GS, Kim GE, Hann B, Donner DB, Warren RS, Venook AP, Bergsland EK, Lee D, Wang Y, Nakakura EK. A Patient-derived Xenograft Model of Pancreatic Neuroendocrine Tumors Identifies Sapanisertib as a Possible New Treatment for Everolimus-resistant Tumors. Mol Cancer Ther. 2018 Dec;17(12):2702–9. PMID: 30254185; PMCID: PMC6279485.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_748a54235b89d896f33f4d8feda18ceb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_554053cfcf288438a7babdb1970bca40 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f6105fd2cd432018a35564fa639998cf http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_a0c755e9eb347c06d4dcb34baaa95780 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_05427f84dcfdb2cf046b7b38cddc5793 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_56a710c6e605d42204740dc299e5ce57 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_54cc86b2640176fd260a2b5fc93f3084 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_58fa4b8ff8905324185f47fdf8940717 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_e95567922e93b768ccf81f71f35236c1 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_eb729f945b63f7adbf128569e831cf0c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8d8596276770819eb03fa7348a00963a http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_289d1213ad102e3f5dc70a050f80c8e8 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_792a5200b5baa2b770c39c85a666a525 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0943ab239e03100720f6afc14c1bb2f6 http://rdf.ncbi.nlm.nih.gov/pubchem/author/ORCID_0000-0001-8590-7741 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_1e54a83e10a3d226dc770c2b86d4020d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0b7a8df39cf7bbb30ba5e1a80ae0d834
date	2018-12-01-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://pubmed.ncbi.nlm.nih.gov/PMC6279485 https://doi.org/10.1158/1535-7163.mct-17-1204 https://pubmed.ncbi.nlm.nih.gov/30254185
isPartOf	https://portal.issn.org/resource/ISSN/1538-8514 https://portal.issn.org/resource/ISSN/1535-7163 http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30097
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	A Patient-derived Xenograft Model of Pancreatic Neuroendocrine Tumors Identifies Sapanisertib as a Possible New Treatment for Everolimus-resistant Tumors
discusses	http://id.nlm.nih.gov/mesh/M000655303 http://id.nlm.nih.gov/mesh/M0018260 http://id.nlm.nih.gov/mesh/M0002373 http://id.nlm.nih.gov/mesh/M0015420 http://id.nlm.nih.gov/mesh/M0543256 http://id.nlm.nih.gov/mesh/M0457532 http://id.nlm.nih.gov/mesh/M0501639 http://id.nlm.nih.gov/mesh/M000602394 http://id.nlm.nih.gov/mesh/M0018226
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D019008Q000187 http://id.nlm.nih.gov/mesh/D001583Q000627 http://id.nlm.nih.gov/mesh/D000068338Q000627 http://id.nlm.nih.gov/mesh/D011720Q000627 http://id.nlm.nih.gov/mesh/D011743Q000627 http://id.nlm.nih.gov/mesh/D010190Q000188 http://id.nlm.nih.gov/mesh/D018358Q000188 http://id.nlm.nih.gov/mesh/D023041
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D045744 http://id.nlm.nih.gov/mesh/D009942Q000737 http://id.nlm.nih.gov/mesh/D047428Q000494 http://id.nlm.nih.gov/mesh/D058570Q000037 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D018358Q000000981 http://id.nlm.nih.gov/mesh/D010190Q000000981 http://id.nlm.nih.gov/mesh/D008819 http://id.nlm.nih.gov/mesh/D000072078 http://id.nlm.nih.gov/mesh/D010190Q000473 http://id.nlm.nih.gov/mesh/D000818 http://id.nlm.nih.gov/mesh/D058570Q000378 http://id.nlm.nih.gov/mesh/D018358Q000473
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6442177 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_8cade790150371557fe0260bcc28b43b http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_effabf75f87a02358f0a8868edaf2c9f http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8607 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5488452 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_bcd6f21312d21a5cf3f0a82f59d9ac97 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45375953 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10163 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID11170867 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10250 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_d0bb789479d34dbc0811f92fc2bc5049

Total number of triples: 83.